A Trial of Grazax in Subjects With Hayfever

Completed · Phase 3 · Has a placebo group

Conditions studied: Allergy

In brief

The trial is performed to evaluate the efficacy and safety of specific immunotherapy with Grazax for treatment of grass pollen induced allergy.

Key facts

Study ID

NCT00421655

Run by

ALK-Abelló A/S

People needed

329

Starts

2006-12-01

Expected to finish

2007-10-01

Last updated by the study team

2015-06-24

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of grass pollen allergy
• Positive skin prick test to grass
• Positive specific IgE to grass

You may not qualify if…

• FEV1 <70% of predicted value

Where it is running

• CompleWare Corporation — Iowa City, Iowa, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.